Related Experiment Video
Updated: Mar 9, 2026
09:56
Detection of Protease Activity by Fluorescent Peptide Zymography
Published on: January 20, 2019
13.7K
Enzymatic Assays for Studying Intramembrane Proteolysis.
D M Bolduc1, D J Selkoe1, M S Wolfe1
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Methods in Enzymology
|January 10, 2017
Summary
Intramembrane-cleaving proteases (I-CLiPs) are crucial enzymes involved in cell signaling and disease. Developing in vitro assays for these membrane-bound proteases, like gamma-secretase, aids therapeutic development.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Proteolysis within cellular membranes is mediated by intramembrane-cleaving proteases (I-CLiPs).
- I-CLiPs hydrolyze transmembrane domains of proteins, regulating essential signaling pathways.
- Dysfunction of I-CLiPs is implicated in diseases such as Alzheimer's, Parkinson's, cancer, and pathogen virulence.
Purpose of the Study:
- To describe in vitro enzymatic assays for studying I-CLiPs, focusing on the Alzheimer's disease-associated gamma-secretase.
- To provide tools for understanding the complex catalytic mechanisms of I-CLiPs.
- To facilitate the development of therapeutic strategies targeting I-CLiPs.
Main Methods:
- Development and application of in vitro enzymatic assays for membrane-bound proteases.
- Utilizing assays to study the gamma-secretase protease involved in Alzheimer's disease.
- Adapting assays for broader application to other I-CLiPs.
Main Results:
- Successful development of in vitro assays for studying gamma-secretase activity.
- These assays have aided in the development of gamma-secretase-targeting therapeutic compounds.
- The assays provide mechanistic insights into the function of various I-CLiPs.
Conclusions:
- In vitro assays are essential for dissecting the mechanisms of membrane-embedded proteases.
- These assays are valuable tools for understanding I-CLiPs and developing treatments for associated diseases.
- Further research into I-CLiP mechanisms can unlock new therapeutic avenues.
